oxendolone

Subscribe to Selected New Research on oxendolone

10 relevant articles (1 outcomes, 3 trials/studies) found for this Bio-Agent

Also Known As:

16 beta-ethyl-17 beta-hydroxyestr-4-en-3-one; 16 beta-ethyl-19-nortestosterone; 16 ethyl-17-hydroxy-4-estren-3-one; EHOO; TSAA 291; TSAA-291; TSAA291; (16 beta,17 beta)-16-ethyl-17-hydroxyestr-4-en-3-one

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 44070

Gonadal Hormones: 245

Gonadal Steroid Hormones: 2145

Testosterone Congeners: 17

Nandrolone: 159

oxendolone: 10

Related Diseases

1.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/01/1989 - "In a randomized triple-blind multicentre study, injections with the anti-androgenic agent oxendolone were compared with placebo in the treatment of benign prostatic hyperplasia" 01/01/1988 - "Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia" 01/01/1988 - "Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia" 01/01/1989 - "Conservative treatment of benign prostatic hyperplasia with the antiandrogen oxendolone in a dose of 200 mg a week cannot be recommended for clinical use." 04/01/1984 - "These findings suggest that oxendolone is the drug of choice for non-surgical treatment of benign prostatic hyperplasia." Get all the results and reference details, order at left...
2.	Prostatism 11/01/1987 - "Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination]" Get all the results and reference details, order at left...
3.	Contracture 11/01/1987 - "We herein report our results of a randomized comparative study on the clinical efficacy of oxendolone, bunazosin hydrochloride (bunazosin) and their combination for the treatment of benign prostatic hypertrophy and bladder neck contracture" Get all the results and reference details, order at left...
4.	Body Weight (Weight, Body) 06/01/1984 - "After successive treatments of male rats with TSAA-291 in an aqueous suspension in daily doses of 5, 15 and 50 mg/kg body weight for two weeks, serum TSAA-291 levels were determined by the radio immunoassay and calculated to be 22.7, 76.9 and 194.9 ng/ml, respectively." 01/01/1979 - "Intramuscular administration of a new steroidal anti-androgen, TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one), in doses of 0.05, 0.5 and 5 mg/kg body weight reduced the in vivo uptake of [3H]testosterone by the ventral prostate of castrated rats of 78, 59 and 37% of the control level, respectively" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 11/30/1990 - "At a 2 mg daily dose for 13 days, (1) and AA560 powerfully inhibited tumor growth in castrated DS mice treated with testosterone propionate but oxendolone had almost no effect" Get all the results and reference details, order at left...
7 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Adrenergic Antagonists (Antiadrenergic Agents)
2.	bunazosin (Andante)
3.	Testosterone Propionate
4.	Testosterone (Sustanon)
5.	Androgen Receptors (Androgen Receptor)
6.	Chlormadinone Acetate (Chlormadinone)
7.	Allylestrenol
8.	anthracene
9.	AA 560
9 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>